Absolute risk of venous and arterial thrombosis in HIV‐infected patients and effects of combination antiretroviral therapy
- 1 September 2006
- journal article
- Published by Wiley in Journal of Thrombosis and Haemostasis
- Vol. 4 (9) , 1928-1930
- https://doi.org/10.1111/j.1538-7836.2006.02047.x
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- The contribution of inherited and acquired thrombophilic defects, alone or combined with antiphospholipid antibodies, to venous and arterial thromboembolism in patients with systemic lupus erythematosusBlood, 2004
- Combination Antiretroviral Therapy and the Risk of Myocardial InfarctionNew England Journal of Medicine, 2003
- Increased risk of myocardial infarction with duration of protease inhibitor therapy in HIV-infected menAIDS, 2003
- A Prospective Study of Asymptomatic Carriers of the Factor V Leiden Mutation To Determine the Incidence of Venous ThromboembolismAnnals of Internal Medicine, 2001
- The Epidemiology of Venous Thromboembolism in the CommunityThrombosis and Haemostasis, 2001
- Epidemiology of thrombosis in HIV-infected individualsAIDS, 2000
- Protein S deficiency in men with long-term human immunodeficiency virus infection [see comments]Blood, 1993
- A prospective study of the incidence of deep‐vein thrombosis within a defined urban populationJournal of Internal Medicine, 1992
- Acquired Protein S DeficiencyJAIDS Journal of Acquired Immune Deficiency Syndromes, 1992